Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT01994811
  4. Details
NCT01994811 Clinical Trial

Eastern Caribbean Health Outcomes Research Network (ECHORN)

Cancer Clinical Trial

— ECHORN  

Official title:
Eastern Caribbean Health Outcomes Research Network (ECHORN)

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01994811
Other study ID # 1108008959
Secondary ID 5U24MD006938
Status Completed
Phase
First received
Last updated
Start date April 2013
Est. completion date June 14, 2018

Study information
Verified date July 2022
Source Yale University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The Eastern Caribbean Health Outcomes Research Network (ECHORN) is a collaborative research study that examines the lifestyles, eating habits, and health behaviors associated with cancer, diabetes and heart disease in adult men and women living in the Eastern Caribbean.

Description:

The Eastern Caribbean Health Outcomes Research Network (ECHORN) has two aims: (1) To form a research collaborative across the Eastern Caribbean islands of Puerto Rico, the U.S. Virgin Islands, Barbados, and Trinidad & Tobago to recruit and follow a community-dwelling adult cohort to estimate the prevalence of known and potential risk factors associated with the development of heart disease, cancer, and diabetes and (2) To enhance health outcomes research leadership capacity in the region through a series of dedicated activities locally and abroad. ECHORN will expand clinical research with racial/ethnic minority populations in a transitioning part of the globe now threatened with an epidemic of noncommunicable chronic diseases (NCD). ECHORN's findings will have direct implications for the health disparities research and policy agenda in the mainland United States. In the long term, the links ECHORN will facilitate with local health policy delegations and global strategic organizational partners will promote the translation of research to improve health outcomes across the region. The collection and storage of biological specimens will also contribute to national biomonitoring projects and has the potential to identify unique risk and protective factors in the development of NCD.

Recruitment information / eligibility
Status Completed
Enrollment 2961
Est. completion date June 14, 2018
Est. primary completion date June 14, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria: - Greater than or equal to 40 years of age - English or Spanish language speaking - Resident of island at least 10 years - Able to provide informed consent - Non-institutionalized at the time of data collection - Stable contact/residential information - No plans to relocate from island within the next 5 years

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Barbados University of the West Indies, Cave Hill Campus Bridgetown
Puerto Rico University of Puerto Rico Medical Sciences Campus San Juan
Trinidad and Tobago University of the West Indies, St. Augustine Campus St. Augustine West Indies
Virgin Islands (U.S.) University of the Virgin Islands Charlotte Amalie

Sponsors (2)
Lead Sponsor Collaborator
Yale University National Institute on Minority Health and Health Disparities (NIMHD)

Countries where clinical trial is conducted

Barbados,  Puerto Rico,  Trinidad and Tobago,  Virgin Islands (U.S.), 

Outcome
Type Measure Description Time frame Safety issue
Primary Prevalence of non-communicable diseases Prevalence of non-communicable diseases, including cancer, heart disease and diabetes. 5 years
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases